$SGRY
Surgery Partners, Inc. Stock $sgry

$sgry Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-K Financial Statement

#000163883316000019 Filed on March 11, 2016

Income Statement

Concept	2014 Q4	2014 Q3	2014 Q2
Revenue	$179.7M	$76.30M	$76.82M
YoY Change
Cost Of Revenue	$120.6M	$45.38M	$45.16M
YoY Change
Gross Profit	$59.10M	$30.93M	$31.65M
YoY Change
Gross Profit Margin	32.89%	40.53%	41.2%
Selling, General & Admin	$25.10M	$11.80M	$11.80M
YoY Change
% of Gross Profit	42.47%	38.16%	37.28%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.500M	$2.834M	$2.800M
YoY Change
% of Gross Profit	11.0%	9.16%	8.85%
Operating Expenses	$31.60M	$56.65M	$14.60M
YoY Change
Operating Profit	$27.50M	$19.65M	$17.05M
YoY Change
Interest Expense	-$28.10M	-$11.26M	-$11.30M
YoY Change
% of Operating Profit	-102.17%	-57.31%	-66.27%
Other Income/Expense, Net	$3.400M	$0.00
YoY Change
Pretax Income	-$33.10M	$8.391M	$9.100M
YoY Change
Income Tax	$3.700M	$7.961M	$2.100M
% Of Pretax Income		94.88%	23.08%
Net Earnings	-$54.26M	-$6.908M	-$606.0K
YoY Change
Net Earnings / Revenue	-30.2%	-9.05%	-0.79%
Basic Earnings Per Share	-$1.69	-$0.22	-$0.02
Diluted Earnings Per Share	-$1.69	-$0.22	-$0.02
COMMON SHARES
Basic Shares Outstanding		31.70M shares
Diluted Shares Outstanding		31.70M shares

Balance Sheet

Concept	2014 Q4	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$74.90M
YoY Change
Cash & Equivalents	$74.92M	$4.386M
Short-Term Investments
Other Short-Term Assets	$9.399M
YoY Change
Inventory	$23.69M
Prepaid Expenses	$7.050M
Receivables	$145.0M
Other Receivables	$8.600M
Total Short-Term Assets	$268.6M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$175.0M
YoY Change
Goodwill	$1.299B
YoY Change	282.53%
Intangibles	$54.89M
YoY Change	103.47%
Long-Term Investments	$36.00M
YoY Change
Other Assets	$5.879M
YoY Change
Total Long-Term Assets	$1.590B
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$268.6M
Total Long-Term Assets	$1.590B
Total Assets	$1.859B
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$43.06M
YoY Change
Accrued Expenses	$46.30M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$22.10M
YoY Change
Total Short-Term Liabilities	$141.4M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$1.390B
YoY Change
Other Long-Term Liabilities	$90.61M
YoY Change
Total Long-Term Liabilities	$90.61M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$141.4M
Total Long-Term Liabilities	$90.61M
Total Liabilities	$232.0M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$322.2M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$264.1M
YoY Change
Total Liabilities & Shareholders Equity	$1.859B
YoY Change

Cashflow Statement

Concept	2014 Q4	2014 Q3	2014 Q2
OPERATING ACTIVITIES
Net Income	-$54.26M	-$6.908M	-$606.0K
YoY Change
Depreciation, Depletion And Amortization	$6.500M	$2.834M	$2.800M
YoY Change
Cash From Operating Activities	-$7.300M	$14.30M	$10.60M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures	-$6.000M	-$1.200M	-$1.200M
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$260.9M	-$600.0K	$0.00
YoY Change
Cash From Investing Activities	-$266.9M	-$1.800M	-$1.200M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	344.8M	-14.10M	-7.400M
YoY Change
NET CHANGE
Cash From Operating Activities	-7.300M	14.30M	10.60M
Cash From Investing Activities	-266.9M	-1.800M	-1.200M
Cash From Financing Activities	344.8M	-14.10M	-7.400M
Net Change In Cash	70.60M	-1.600M	2.000M
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$7.300M	$14.30M	$10.60M
Capital Expenditures	-$6.000M	-$1.200M	-$1.200M
Free Cash Flow	-$1.300M	$15.50M	$11.80M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q4	sgry	Business Combination Consideration Transferred Payable Current BusinessCombinationConsiderationTransferredPayableCurrent	16768000	USD
CY2015Q3	sgry	Collaborative Tax Agreement Percentageof Cash Savings Requiredto Pay CollaborativeTaxAgreementPercentageofCashSavingsRequiredtoPay	0.85
CY2015Q4	sgry	Lease Obligation Noncurrent LeaseObligationNoncurrent	53927000	USD
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-12-31
CY2015	dei	Document Type DocumentType	10-K
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0001638833
CY2016Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48156990	shares
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2015Q2	dei	Entity Public Float EntityPublicFloat	0	USD
CY2015	dei	Entity Registrant Name EntityRegistrantName	Surgery Partners, Inc.
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015Q4	sgry	Third Party Settlements Payable Current ThirdPartySettlementsPayableCurrent	5222000	USD
CY2015Q4	sgry	Third Party Settlements Payable Current ThirdPartySettlementsPayableCurrent	5200000	USD
CY2015Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	5476000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Capital Leased Assets AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets	70238000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	14049000	USD
CY2015Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	1608000	USD
CY2015Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	1606000	USD
CY2015Q4	us-gaap	Interest Payable Current InterestPayableCurrent	5410000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	22133000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	10777000	USD
CY2015Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	4211000	USD
CY2015Q4	us-gaap	Payables To Customers PayablesToCustomers	11424000	USD
CY2015Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7409000	USD
CY2015Q4	us-gaap	Security Deposit SecurityDeposit	2475000	USD
CY2015Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	9500000	USD
CY2015Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1977000	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	6353000	USD
CY2014	sgry	Incentive Payments Recognizedfor Certain Hospitalsand Physician Practices That Demonstrate Meaningful Useof Certified Electronic Health Record Technology IncentivePaymentsRecognizedforCertainHospitalsandPhysicianPracticesThatDemonstrateMeaningfulUseofCertifiedElectronicHealthRecordTechnology	3356000	USD
CY2015	sgry	Incentive Payments Recognizedfor Certain Hospitalsand Physician Practices That Demonstrate Meaningful Useof Certified Electronic Health Record Technology IncentivePaymentsRecognizedforCertainHospitalsandPhysicianPracticesThatDemonstrateMeaningfulUseofCertifiedElectronicHealthRecordTechnology	1761000	USD
CY2013	sgry	Amortizationof Unfavorable Lease Liability AmortizationofUnfavorableLeaseLiability	0	USD
CY2014Q4	sgry	Acquisitionescrowreceivablecurrent Acquisitionescrowreceivablecurrent	0	USD
CY2015Q4	sgry	Acquisitionescrowreceivablecurrent Acquisitionescrowreceivablecurrent	8000000	USD
CY2014	sgry	Amortizationof Unfavorable Lease Liability AmortizationofUnfavorableLeaseLiability	72000	USD
CY2015	sgry	Amortizationof Unfavorable Lease Liability AmortizationofUnfavorableLeaseLiability	431000	USD
CY2014Q4	sgry	Business Combination Consideration Transferred Payable Current BusinessCombinationConsiderationTransferredPayableCurrent	0	USD
CY2014Q4	sgry	Business Combination Consideration Transferred Payable Noncurrent BusinessCombinationConsiderationTransferredPayableNoncurrent	16768000	USD
CY2015Q4	sgry	Business Combination Consideration Transferred Payable Noncurrent BusinessCombinationConsiderationTransferredPayableNoncurrent	0	USD
CY2014Q4	sgry	Business Combination Indemnification Assets Receivable BusinessCombinationIndemnificationAssetsReceivable	1072000	USD
CY2015Q4	sgry	Business Combination Indemnification Assets Receivable BusinessCombinationIndemnificationAssetsReceivable	1072000	USD
CY2013	sgry	Debt Instrument Prepayment Penalty Amount DebtInstrumentPrepaymentPenaltyAmount	0	USD
CY2014	sgry	Debt Instrument Prepayment Penalty Amount DebtInstrumentPrepaymentPenaltyAmount	0	USD
CY2015	sgry	Debt Instrument Prepayment Penalty Amount DebtInstrumentPrepaymentPenaltyAmount	7305000	USD
CY2014	sgry	Decreaseof Revenueas Resultof Changesin Estimatesto Thirdparty Settlements Relatedto Prior Years DecreaseofRevenueasResultofChangesinEstimatestoThirdpartySettlementsRelatedtoPriorYears	104000	USD
CY2014Q4	sgry	Deferred Tax Asset Tax Receivable Agreement DeferredTaxAssetTaxReceivableAgreement	0	USD
CY2015Q4	sgry	Deferred Tax Asset Tax Receivable Agreement DeferredTaxAssetTaxReceivableAgreement	2750000	USD
CY2014Q4	sgry	Deferred Tax Assets Basis Differencesof Partnershipsand Joint Ventures DeferredTaxAssetsBasisDifferencesofPartnershipsandJointVentures	16131000	USD
CY2015Q4	sgry	Deferred Tax Assets Basis Differencesof Partnershipsand Joint Ventures DeferredTaxAssetsBasisDifferencesofPartnershipsandJointVentures	0	USD
CY2014Q4	sgry	Deferred Tax Assets Supplemental Executive Retirement Savings Program DeferredTaxAssetsSupplementalExecutiveRetirementSavingsProgram	527000	USD
CY2015Q4	sgry	Deferred Tax Assets Supplemental Executive Retirement Savings Program DeferredTaxAssetsSupplementalExecutiveRetirementSavingsProgram	685000	USD
CY2014Q4	sgry	Deferred Tax Assets Tax Deferred Expense Compensationand Benefits Compensated Absencesand Incentive Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsCompensatedAbsencesandIncentiveCompensation	2079000	USD
CY2015Q4	sgry	Deferred Tax Assets Tax Deferred Expense Compensationand Benefits Compensated Absencesand Incentive Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsCompensatedAbsencesandIncentiveCompensation	2212000	USD
CY2014Q4	sgry	Deferred Tax Assets Tax Deferred Expense Deferred Financing Costs DeferredTaxAssetsTaxDeferredExpenseDeferredFinancingCosts	4386000	USD
CY2015Q4	sgry	Deferred Tax Assets Tax Deferred Expense Deferred Financing Costs DeferredTaxAssetsTaxDeferredExpenseDeferredFinancingCosts	3083000	USD
CY2014Q4	sgry	Deferred Tax Assets Unrecognized Tax Benefit DeferredTaxAssetsUnrecognizedTaxBenefit	440000	USD
CY2015Q4	sgry	Deferred Tax Assets Unrecognized Tax Benefit DeferredTaxAssetsUnrecognizedTaxBenefit	244000	USD
CY2014Q4	sgry	Deferred Tax Liabilities Basis Differencesof Partnershipsand Joint Ventures DeferredTaxLiabilitiesBasisDifferencesofPartnershipsandJointVentures	43195000	USD
CY2015Q4	sgry	Deferred Tax Liabilities Basis Differencesof Partnershipsand Joint Ventures DeferredTaxLiabilitiesBasisDifferencesofPartnershipsandJointVentures	46494000	USD
CY2014Q4	sgry	Deferred Tax Liabilities Deferred Expense Deferred Rent DeferredTaxLiabilitiesDeferredExpenseDeferredRent	515000	USD
CY2015Q4	sgry	Deferred Tax Liabilities Deferred Expense Deferred Rent DeferredTaxLiabilitiesDeferredExpenseDeferredRent	0	USD
CY2013	sgry	Effective Income Tax Rate Reconciliation Expirationof Carryforwardsand Stock Option Forfeitures Amount EffectiveIncomeTaxRateReconciliationExpirationofCarryforwardsandStockOptionForfeituresAmount	2524000	USD
CY2014	sgry	Effective Income Tax Rate Reconciliation Expirationof Carryforwardsand Stock Option Forfeitures Amount EffectiveIncomeTaxRateReconciliationExpirationofCarryforwardsandStockOptionForfeituresAmount	1286000	USD
CY2015	sgry	Effective Income Tax Rate Reconciliation Expirationof Carryforwardsand Stock Option Forfeitures Amount EffectiveIncomeTaxRateReconciliationExpirationofCarryforwardsandStockOptionForfeituresAmount	0	USD
CY2013	sgry	Effective Income Tax Rate Reconciliation Nondeductible Mergerand Public Offering Costs Amount EffectiveIncomeTaxRateReconciliationNondeductibleMergerandPublicOfferingCostsAmount	0	USD
CY2014	sgry	Effective Income Tax Rate Reconciliation Nondeductible Mergerand Public Offering Costs Amount EffectiveIncomeTaxRateReconciliationNondeductibleMergerandPublicOfferingCostsAmount	4230000	USD
CY2015	sgry	Effective Income Tax Rate Reconciliation Nondeductible Mergerand Public Offering Costs Amount EffectiveIncomeTaxRateReconciliationNondeductibleMergerandPublicOfferingCostsAmount	3442000	USD
CY2015	sgry	Effective Income Tax Rate Reconciliation Tax Receivable Agreement Amount EffectiveIncomeTaxRateReconciliationTaxReceivableAgreementAmount	39428000	USD
CY2014Q4	sgry	Escrow Deposit Current EscrowDepositCurrent	0	USD
CY2015Q4	sgry	Escrow Deposit Current EscrowDepositCurrent	13984000	USD
CY2014Q4	sgry	Escrow Deposit Noncurrent EscrowDepositNoncurrent	16232000	USD
CY2015Q4	sgry	Escrow Deposit Noncurrent EscrowDepositNoncurrent	8408000	USD
CY2014Q4	sgry	Escrow Liability Current EscrowLiabilityCurrent	0	USD
CY2015Q4	sgry	Escrow Liability Current EscrowLiabilityCurrent	13984000	USD
CY2014Q4	sgry	Escrow Liability Noncurrent EscrowLiabilityNoncurrent	16232000	USD
CY2015Q4	sgry	Escrow Liability Noncurrent EscrowLiabilityNoncurrent	8408000	USD
CY2013Q2	sgry	Gain Contingency Unrecorded Amount Overstated Accounts Receivable GainContingencyUnrecordedAmountOverstatedAccountsReceivable	10800000	USD
CY2013	sgry	Incentive Payments Recognizedfor Certain Hospitalsand Physician Practices That Demonstrate Meaningful Useof Certified Electronic Health Record Technology IncentivePaymentsRecognizedforCertainHospitalsandPhysicianPracticesThatDemonstrateMeaningfulUseofCertifiedElectronicHealthRecordTechnology	0	USD
CY2014	sgry	Intangible Assets Professional Recruitment Expense IntangibleAssetsProfessionalRecruitmentExpense	108000	USD
CY2015	sgry	Intangible Assets Professional Recruitment Expense IntangibleAssetsProfessionalRecruitmentExpense	813000	USD
CY2013	sgry	Intereston Contingent Consideration Obligation InterestonContingentConsiderationObligation	892000	USD
CY2014	sgry	Intereston Contingent Consideration Obligation InterestonContingentConsiderationObligation	964000	USD
CY2015	sgry	Intereston Contingent Consideration Obligation InterestonContingentConsiderationObligation	1041000	USD
CY2014Q4	sgry	Lease Obligation Noncurrent LeaseObligationNoncurrent	50749000	USD
CY2014Q4	sgry	Long Term Tax Receivable Agreement Liability LongTermTaxReceivableAgreementLiability	0	USD
CY2015Q4	sgry	Long Term Tax Receivable Agreement Liability LongTermTaxReceivableAgreementLiability	119700000	USD
CY2015Q4	sgry	Long Term Tax Receivable Agreement Liability LongTermTaxReceivableAgreementLiability	119655000	USD
CY2014Q4	sgry	Medical Malpractice Liability Noncurrent MedicalMalpracticeLiabilityNoncurrent	4253000	USD
CY2015Q4	sgry	Medical Malpractice Liability Noncurrent MedicalMalpracticeLiabilityNoncurrent	6339000	USD
CY2013	sgry	Non Controlling Interest Acquisitionsand Disposalsof Interestsheldby Non Controlling Interest Holders Net NonControllingInterestAcquisitionsandDisposalsofInterestsheldbyNonControllingInterestHoldersNet	-396000	USD
CY2014	sgry	Non Controlling Interest Acquisitionsand Disposalsof Interestsheldby Non Controlling Interest Holders Net NonControllingInterestAcquisitionsandDisposalsofInterestsheldbyNonControllingInterestHoldersNet	202657000	USD
CY2015	sgry	Non Controlling Interest Acquisitionsand Disposalsof Interestsheldby Non Controlling Interest Holders Net NonControllingInterestAcquisitionsandDisposalsofInterestsheldbyNonControllingInterestHoldersNet	3486000	USD
CY2015Q4	sgry	Number Of Surgical Facilities Owned NumberOfSurgicalFacilitiesOwned	101	surgical_facility
CY2015Q4	sgry	Numberof Surgical Facilities Owned Consolidated NumberofSurgicalFacilitiesOwnedConsolidated	90	surgical_facility
CY2015Q4	sgry	Numberof Surgical Facilities Owned Majority Interest NumberofSurgicalFacilitiesOwnedMajorityInterest	72	surgical_facility
CY2015	sgry	Numberof Surgical Facilities Relatedto Revenue Adjustment NumberofSurgicalFacilitiesRelatedtoRevenueAdjustment	2	surgical_facility
CY2015Q4	sgry	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Current OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsCurrent	1043000	USD
CY2015Q4	sgry	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Thereafter OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsThereafter	2231000	USD
CY2015Q4	sgry	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Totals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsTotals	6638000	USD
CY2015Q4	sgry	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentalsin Five Years OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsinFiveYears	468000	USD
CY2015Q4	sgry	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentalsin Four Years OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsinFourYears	658000	USD
CY2015Q4	sgry	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentalsin Three Years OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsinThreeYears	1137000	USD
CY2015Q4	sgry	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentalsin Two Years OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsinTwoYears	1101000	USD
CY2015Q2	sgry	Operating Leasesof Lessee Numberof Leases Terminated OperatingLeasesofLesseeNumberofLeasesTerminated	4	Lease
CY2014Q4	sgry	Optical Products Receivable OpticalProductsReceivable	7556000	USD
CY2014Q4	sgry	Optical Products Receivable OpticalProductsReceivable	7600000	USD
CY2015Q4	sgry	Optical Products Receivable OpticalProductsReceivable	8434000	USD
CY2013	sgry	Paymentsof Distributionto Parent PaymentsofDistributiontoParent	131013000	USD
CY2014	sgry	Paymentsof Distributionto Parent PaymentsofDistributiontoParent	93000000	USD
CY2015	sgry	Paymentsof Distributionto Parent PaymentsofDistributiontoParent	0	USD
CY2014	sgry	Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2768000	USD
CY2015	sgry	Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	19936000	USD
CY2014	sgry	Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests	191278000	USD
CY2015	sgry	Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests	-6830000	USD
CY2013	sgry	Stockholders Equity Distributionsto Parent StockholdersEquityDistributionstoParent	131013000	USD
CY2014	sgry	Stockholders Equity Distributionsto Parent StockholdersEquityDistributionstoParent	93000000	USD
CY2013	sgry	Tax Receivable Agreement Expense TaxReceivableAgreementExpense	0	USD
CY2014	sgry	Tax Receivable Agreement Expense TaxReceivableAgreementExpense	0	USD
CY2015	sgry	Tax Receivable Agreement Expense TaxReceivableAgreementExpense	119911000	USD
CY2013	sgry	Terminationof Management Agreementand Ipo Costs TerminationofManagementAgreementandIPOCosts	0	USD
CY2014	sgry	Terminationof Management Agreementand Ipo Costs TerminationofManagementAgreementandIPOCosts	0	USD
CY2015	sgry	Terminationof Management Agreementand Ipo Costs TerminationofManagementAgreementandIPOCosts	5834000	USD
CY2013	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1054000	USD
CY2014	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	3252000	USD
CY2014Q4	sgry	Third Party Settlements Payable Current ThirdPartySettlementsPayableCurrent	11700000	USD
CY2014Q4	sgry	Third Party Settlements Payable Current ThirdPartySettlementsPayableCurrent	11708000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	43063000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	45341000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	144960000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	177757000	USD
CY2014Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	5552000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Capital Leased Assets AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets	55697000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	58151000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	316294000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	640000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	455000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	942000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7500000	USD
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3234000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5028000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5329000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	18322000	USD
CY2013	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	4091000	USD
CY2014	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	9208000	USD
CY2015	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	10585000	USD
CY2013	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2430000	USD
CY2014	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3746000	USD
CY2015	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6263000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4900000	USD
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5214000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9091000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9100000	USD
CY2014Q4	us-gaap	Assets Assets	1858794000	USD
CY2015Q4	us-gaap	Assets Assets	2106684000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	268649000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	310957000	USD
CY2013Q2	us-gaap	Business Combination Assets Arising From Contingencies Amount Recognized BusinessCombinationAssetsArisingFromContingenciesAmountRecognized	14000000	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	13009000	USD
CY2013	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	0	USD
CY2014	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	21690000	USD
CY2015	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	17920000	USD
CY2014Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	10755000	USD
CY2015Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	11316000	USD
CY2015	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	5443000	USD
CY2014Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	13300000	USD
CY2014Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	6800000	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	13235000	USD
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48156990	shares
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2014Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	0	USD
CY2015Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	482000	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	469000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5232000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13026000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74920000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	57933000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	7794000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	61894000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-16987000	USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48156990	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1000	shares
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9062000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-65897000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1429000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	26789000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	38845000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	71416000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	17727000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-27052000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	72845000	USD
CY2013	us-gaap	Cost Of Revenue CostOfRevenue	169844000	USD
CY2014Q1	us-gaap	Cost Of Revenue CostOfRevenue	43050000	USD
CY2014Q2	us-gaap	Cost Of Revenue CostOfRevenue	45164000	USD
CY2014Q3	us-gaap	Cost Of Revenue CostOfRevenue	45377000	USD
CY2014Q4	us-gaap	Cost Of Revenue CostOfRevenue	120587000	USD
CY2014	us-gaap	Cost Of Revenue CostOfRevenue	254178000	USD
CY2015Q1	us-gaap	Cost Of Revenue CostOfRevenue	155773000	USD
CY2015Q2	us-gaap	Cost Of Revenue CostOfRevenue	161558000	USD
CY2015Q3	us-gaap	Cost Of Revenue CostOfRevenue	168821000	USD
CY2015Q4	us-gaap	Cost Of Revenue CostOfRevenue	183174000	USD
CY2015	us-gaap	Cost Of Revenue CostOfRevenue	669326000	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1669000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	909000	USD
CY2014Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	1415000	USD
CY2014Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	1402000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	0	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	49284000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	114000	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-132311000	USD
CY2014Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	5630000	USD
CY2015Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	4246000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7136000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	14089000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-149891000	USD
CY2014Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	61385000	USD
CY2015Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	63995000	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	748000	USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	854000	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-17580000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	3513000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	2052000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	155010000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	165049000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	94105000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	0	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	94105000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	12101000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	158100000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	123709000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	146663000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1597000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1748000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	362000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	367000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	760000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	242000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	980000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1846000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	526000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	869000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	0	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	2288000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	142909000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	142900000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6900000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6949000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	16159000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	16083000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	49170000	USD
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.69
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.04
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	49200000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	0	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	466000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	612000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1050000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	806000	USD
CY2015Q4	us-gaap	Deferred Taxes Business Combination Valuation Allowance Allocated To Contributed Capital DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital	2100000	USD
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	516000	USD
CY2014	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	754000	USD
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2200000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11663000	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15061000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	34545000	USD
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.69
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.04
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	22370000	USD
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	26307000	USD
CY2015Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1100000	USD
CY2014Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	5000000	USD
CY2015Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	6300000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	16992000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	9707000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2616000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5764000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	6316000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	8220000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	49615000	USD
CY2014	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	33234000	USD
CY2015	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	8584000	USD
CY2015Q2	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	-4600000	USD
CY2013	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-2482000	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1804000	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2097000	USD
CY2013	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9863000	USD
CY2014	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-23414000	USD
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-16100000	USD
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-16102000	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26339000	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31452000	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	55992000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	339521000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	1298753000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	1407927000	USD
CY2014	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	959232000	USD
CY2015	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	113812000	USD
CY2013	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	581000	USD
CY2014	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2014	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	0	USD
CY2015	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	3761000	USD
CY2014	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	0	USD
CY2015	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	8399000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	25297000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11294000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-76137000	USD
CY2013	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2014	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1264000	USD
CY2015	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3777000	USD
CY2013	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	0	USD
CY2014	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	713000	USD
CY2015	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	543000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7570000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15758000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-148982000	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4067000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	29336000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-137721000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-2143000	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	8601000	USD
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3840000	USD
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-26648000	USD
CY2013	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	9108000	USD
CY2014	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	13207000	USD
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	181000	USD
CY2013	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	836000	USD
CY2015	us-gaap	Income Tax Reconciliation Tax Contingencies Other IncomeTaxReconciliationTaxContingenciesOther	-10000	USD
CY2013	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	538000	USD
CY2014	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	676000	USD
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1093000	USD
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1100000	USD
CY2015	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	24996000	USD
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	242000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	381000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-4419000	USD
CY2015	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-1574000	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	408000	USD
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1402000	USD
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1059000	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Contingencies Other IncomeTaxReconciliationTaxContingenciesOther	0	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Contingencies Other IncomeTaxReconciliationTaxContingenciesOther	589000	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9722000	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	20161000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	48783000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	314000	USD
CY2014	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-418000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-4439000	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	26976000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	54888000	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	53568000	USD
CY2013	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-32929000	USD
CY2014	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-62101000	USD
CY2015	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-100980000	USD
CY2013	us-gaap	Interest Paid Net InterestPaidNet	31101000	USD
CY2014	us-gaap	Interest Paid Net InterestPaidNet	50377000	USD
CY2015	us-gaap	Interest Paid Net InterestPaidNet	96799000	USD
CY2014Q4	us-gaap	Interest Payable Current InterestPayableCurrent	7027000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	23692000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	25591000	USD
CY2014Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	33441000	USD
CY2015Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	34103000	USD
CY2013	us-gaap	Labor And Related Expense LaborAndRelatedExpense	70923000	USD
CY2014	us-gaap	Labor And Related Expense LaborAndRelatedExpense	101976000	USD
CY2015	us-gaap	Labor And Related Expense LaborAndRelatedExpense	261685000	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	13500000	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	18800000	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	40100000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1858794000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2106684000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	181314000	USD
CY2015	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.005
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	141391000	USD
CY2014Q4	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	182000	USD
CY2015Q4	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	212000	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	1285982000	USD
CY2014Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1339266000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1230328000	USD
CY2014Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	22088000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	27272000	USD
CY2014Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	1361354000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	1257600000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	248032000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	27272000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	827497000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	137420000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	14679000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	31082000	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	293618000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	301955000	USD
CY2013	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	25253000	USD
CY2014	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	32414000	USD
CY2015	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	49784000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-37662000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	310961000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	33374000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3622000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-271016000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-134842000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	49078000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	21949000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	84481000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-9062000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-4119000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-606000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-6908000	USD
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	-54264000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-65897000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-6762000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-5426000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-3122000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	16739000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	1429000	USD
CY2013	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	26789000	USD
CY2014Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6377000	USD
CY2014Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	7631000	USD
CY2014Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	7338000	USD
CY2014Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	17499000	USD
CY2014	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	38845000	USD
CY2013	us-gaap	Notes Issued1 NotesIssued1	0	USD
CY2014	us-gaap	Notes Issued1 NotesIssued1	0	USD
CY2015	us-gaap	Notes Issued1 NotesIssued1	7430000	USD
CY2015	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	4	Entity
CY2015	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2015Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	17250000	USD
CY2015Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	17905000	USD
CY2015	us-gaap	Number Of Reporting Units NumberOfReportingUnits	6	reporting_unit
CY2015Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	29	state
CY2014Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	2427000	USD
CY2015Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	1996000	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	226373000	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	352482000	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	815137000	USD
CY2015Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	16906000	USD
CY2015Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	19355000	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	71416000	USD
CY2014	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	4079000	USD
CY2015	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	17616000	USD
CY2013	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	17727000	USD
CY2014	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-31131000	USD
CY2015	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	55229000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	58226000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	50807000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	144754000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	256392000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	36443000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	21401000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	25677000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	29721000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	33019000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	110131000	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	14048000	USD
CY2014	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	19389000	USD
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	44848000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	16918000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	9399000	USD
CY2014Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	2099000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5879000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8504000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2013	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	13775000	USD
CY2014	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	20561000	USD
CY2015	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	54127000	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	53870000	USD
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	68410000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	90610000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	85613000	USD
CY2013	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	297000	USD
CY2014	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-6000	USD
CY2015	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-525000	USD
CY2014Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	1989000	USD
CY2015Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	7694000	USD
CY2013	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	USD
CY2014	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	USD
CY2015	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	119911000	USD
CY2014Q4	us-gaap	Payables To Customers PayablesToCustomers	9476000	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3143000	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2013	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
CY2014	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	17840000	USD
CY2015	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
CY2013	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	4974000	USD
CY2014	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7496000	USD
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2013	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	-503000	USD
CY2014	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	-278000	USD
CY2015	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	12175000	USD
CY2013	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	25253000	USD
CY2014	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	35182000	USD
CY2015	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	69720000	USD
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	486000	USD
CY2014	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	263280000	USD
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	112596000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4150000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7736000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33439000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24005000	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	34620000	USD
CY2014Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7050000	USD
CY2013	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	1014000	USD
CY2014	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2015	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	11193000	USD
CY2013	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2014	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2015	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	250979000	USD
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	462983000	USD
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1477288000	USD
CY2015	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	196366000	USD
CY2013	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2014	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-70000	USD
CY2015	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	3558000	USD
CY2013	us-gaap	Professional Fees ProfessionalFees	7372000	USD
CY2014	us-gaap	Professional Fees ProfessionalFees	18028000	USD
CY2015	us-gaap	Professional Fees ProfessionalFees	66583000	USD
CY2013	us-gaap	Profit Loss ProfitLoss	17727000	USD
CY2014Q1	us-gaap	Profit Loss ProfitLoss	2258000	USD
CY2014Q2	us-gaap	Profit Loss ProfitLoss	7025000	USD
CY2014Q3	us-gaap	Profit Loss ProfitLoss	430000	USD
CY2014Q4	us-gaap	Profit Loss ProfitLoss	-36765000	USD
CY2014	us-gaap	Profit Loss ProfitLoss	-27052000	USD
CY2015Q1	us-gaap	Profit Loss ProfitLoss	10488000	USD
CY2015Q2	us-gaap	Profit Loss ProfitLoss	12479000	USD
CY2015Q3	us-gaap	Profit Loss ProfitLoss	13784000	USD
CY2015Q4	us-gaap	Profit Loss ProfitLoss	36094000	USD
CY2015	us-gaap	Profit Loss ProfitLoss	72845000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross Excluding Capital Leased Assets PropertyPlantAndEquipmentGrossExcludingCapitalLeasedAssets	230703000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross Excluding Capital Leased Assets PropertyPlantAndEquipmentGrossExcludingCapitalLeasedAssets	254788000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	175006000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	184550000	USD
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5885000	USD
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	9509000	USD
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	23578000	USD
CY2013Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	USD
CY2014Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	192589000	USD
CY2015Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	183439000	USD
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	339908000	USD
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1009874000	USD
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	328329000	USD
CY2014Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	316000	USD
CY2015Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	316000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-322233000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-320804000	USD
CY2013	us-gaap	Revenues Revenues	284599000	USD
CY2014Q1	us-gaap	Revenues Revenues	70480000	USD
CY2014Q2	us-gaap	Revenues Revenues	76815000	USD
CY2014Q3	us-gaap	Revenues Revenues	76303000	USD
CY2014Q4	us-gaap	Revenues Revenues	179691000	USD
CY2014	us-gaap	Revenues Revenues	403289000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	942000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	7502000	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0	shares
CY2015Q1	us-gaap	Revenues Revenues	224143000	USD
CY2015Q2	us-gaap	Revenues Revenues	232827000	USD
CY2015Q3	us-gaap	Revenues Revenues	239599000	USD
CY2015Q4	us-gaap	Revenues Revenues	263322000	USD
CY2015	us-gaap	Revenues Revenues	959891000	USD
CY2014Q4	us-gaap	Security Deposit SecurityDeposit	2196000	USD
CY2014Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	7400000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	455000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	8488	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8488	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.03
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	20.03
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2015	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	339000	USD
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	250979000	USD
CY2014	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3143000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	-264082000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	-4028000	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	124105000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14375000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29536000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	297927000	USD
CY2013	us-gaap	Supplies Expense SuppliesExpense	63726000	USD
CY2014	us-gaap	Supplies Expense SuppliesExpense	94224000	USD
CY2015	us-gaap	Supplies Expense SuppliesExpense	242083000	USD
CY2014Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	3189000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2755000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1403000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	996000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	492000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	357000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	322000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	1766000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	0	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	66000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	923000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	136000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	548000	USD
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-136000000	USD
CY2013	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2014	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2015	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1398154	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31815520	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32295364	shares
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37464387	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31815520	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32295364	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36066233	shares
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All adjustments are of a normal, recurring nature. Actual results could differ from those estimates.</font></div></div>
CY2015	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:24px;text-indent:-24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Organization</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">Surgery Partners, Inc.</font><font style="font-family:inherit;font-size:9pt;">,</font><font style="font-family:inherit;font-size:10pt;"> a </font><font style="font-family:inherit;font-size:9pt;">Delaware corporation (together with its subsidiaries, the “Company”), was formed April 2, 2015, as a holding company for the purpose of facilitating an initial public offering (the “IPO”) of shares of common stock. Prior to September 30, 2015, the Company conducted business through Surgery Center Holdings, Inc. and its subsidiaries. Surgery Center Holdings, LLC was and is the sole direct owner of the equity interests of Surgery Center Holdings, Inc. and had no other material assets. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On September 30, 2015, Surgery Partners, Inc. became the direct parent and sole member of Surgery Center Holdings, LLC (the "Reorganization"). In the Reorganization, all of the equity interests held by the pre-IPO Owners of Surgery Center Holdings, LLC were contributed to Surgery Partners, Inc. in exchange for </font><font style="font-family:inherit;font-size:9pt;">33,871,990</font><font style="font-family:inherit;font-size:9pt;"> shares of common stock of Surgery Partners, Inc. and certain rights to additional payments under a tax receivable agreement. After giving effect to the Reorganization, Surgery Partners, Inc. is a holding company, and its sole material asset is an equity interest in Surgery Center Holdings, LLC. The Company's consolidated financial statements for periods prior to the Reorganization represent the historical operating results and financial position of Surgery Center Holdings, Inc. and certain of its subsidiaries.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On </font><font style="font-family:inherit;font-size:9pt;">October 1, 2015</font><font style="font-family:inherit;font-size:9pt;">, the Company completed its IPO of </font><font style="font-family:inherit;font-size:9pt;">14,285,000</font><font style="font-family:inherit;font-size:9pt;"> shares of common stock at an offering price of </font><font style="font-family:inherit;font-size:9pt;">$19.00</font><font style="font-family:inherit;font-size:9pt;"> per share. On </font><font style="font-family:inherit;font-size:9pt;">October 6, 2015</font><font style="font-family:inherit;font-size:9pt;">, the Company received net proceeds from the sale of common stock in this offering of </font><font style="font-family:inherit;font-size:9pt;">$255.8 million</font><font style="font-family:inherit;font-size:9pt;">, after deducting underwriting discounts and other fees of </font><font style="font-family:inherit;font-size:9pt;">$15.6 million</font><font style="font-family:inherit;font-size:9pt;">. These net proceeds were used to repay a portion of the borrowings outstanding under the 2014 Second Lien and to pay fees associated with this offering. The Company also incurred an additional </font><font style="font-family:inherit;font-size:9pt;">$4.8 million</font><font style="font-family:inherit;font-size:9pt;"> in costs directly related to the IPO.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On </font><font style="font-family:inherit;font-size:9pt;">November 3, 2014</font><font style="font-family:inherit;font-size:9pt;">, the Company completed the acquisition of Symbion Holdings Corp. ("Symbion") ("the Merger"), which added </font><font style="font-family:inherit;font-size:9pt;">55</font><font style="font-family:inherit;font-size:9pt;"> surgical facilities, including </font><font style="font-family:inherit;font-size:9pt;">49</font><font style="font-family:inherit;font-size:9pt;"> ambulatory surgery centers ("ASCs") and </font><font style="font-family:inherit;font-size:9pt;">six</font><font style="font-family:inherit;font-size:9pt;"> surgical hospitals, to its network of existing facilities. The Company acquired Symbion for a purchase price of </font><font style="font-family:inherit;font-size:9pt;">$792.0 million</font><font style="font-family:inherit;font-size:9pt;"> pursuant to the terms of an Agreement and Plan of Merger dated as of </font><font style="font-family:inherit;font-size:9pt;">June 13, 2014</font><font style="font-family:inherit;font-size:9pt;">. The Symbion acquisition was financed through the issuance of approximately </font><font style="font-family:inherit;font-size:9pt;">$1.4 billion</font><font style="font-family:inherit;font-size:9pt;"> under the Company's Term Loans and Revolving Facility. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">As of </font><font style="font-family:inherit;font-size:9pt;">December 31, 2015</font><font style="font-family:inherit;font-size:9pt;">, the Company owned and operated a national network of surgical facilities and ancillary services in </font><font style="font-family:inherit;font-size:9pt;">29</font><font style="font-family:inherit;font-size:9pt;"> states.  The surgical facilities, which include ASCs and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, otolaryngology</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:9pt;">("ENT"), gastroenterology</font><font style="font-family:inherit;font-size:10pt;"> ("</font><font style="font-family:inherit;font-size:9pt;">GI"), general surgery, ophthalmology, orthopedics, cardiology and pain management. The Company's surgical hospitals provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, optical services and specialty pharmacy services. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> As of </font><font style="font-family:inherit;font-size:9pt;">December 31, 2015</font><font style="font-family:inherit;font-size:9pt;">, the Company owned or operated a portfolio of </font><font style="font-family:inherit;font-size:9pt;">101</font><font style="font-family:inherit;font-size:9pt;"> surgical facilities, comprised of </font><font style="font-family:inherit;font-size:9pt;">96</font><font style="font-family:inherit;font-size:9pt;"> ASCs and </font><font style="font-family:inherit;font-size:9pt;">five</font><font style="font-family:inherit;font-size:9pt;"> surgical hospitals. The Company owns these facilities in partnership with physicians and, in some cases, healthcare systems in the markets and communities it serves. The Company owned a majority interest in </font><font style="font-family:inherit;font-size:9pt;">72</font><font style="font-family:inherit;font-size:9pt;"> of the surgical facilities and consolidated </font><font style="font-family:inherit;font-size:9pt;">90</font><font style="font-family:inherit;font-size:9pt;"> of these facilities for financial reporting purposes. In addition, the Company owned or operated a network of </font><font style="font-family:inherit;font-size:9pt;">46</font><font style="font-family:inherit;font-size:9pt;"> physician practices.</font></div></div>
CY2015	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Certain reclassifications have been made to the comparative periods' financial statements to conform to the current year presentation. The reclassifications primarily related to the presentation of certain expenses within costs of revenue and had no impact on the Company's consolidated financial position, results of operations or cash flows.</font></div></div>
CY2015	us-gaap	Revenue Recognition Sales Of Services RevenueRecognitionSalesOfServices	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company recognizes revenues in the period in which the services are performed. Patient service revenues and receivables from third-party payors are recorded net of estimated contractual adjustments and allowances, which the Company estimates based on the historical trend of its cash collections and contractual write-offs, accounts receivable agings, established fee schedules, contracts with payors and procedure statistics.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Other service revenues.</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:9pt;"> Optical service revenues consist of product sales from the Company's optical laboratories as well as handling charges billed to the members of the Company's optical products purchasing organization and sales from the Company's marketing products and services business. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. Revenue is recognized as orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given. The Company's optical laboratories manufacture and distribute corrective lenses and eyeglasses to ophthalmologists and optometrists. Revenue is recognized when product is shipped, net of allowance for discounts. The Company's marketing products and services businesses recognize revenue when product is shipped or services are rendered. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which services are rendered.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Patient service revenues.</font><font style="font-family:inherit;font-size:9pt;">  The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications.  The fee does not normally include professional fees charged by the patient’s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor.  However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians. Patient service revenues are recognized on the date of service, net of estimated contractual adjustments and discounts from third-party payors, including Medicare and Medicaid.  Changes in estimated contractual adjustments and discounts are recorded in the period of change. During the </font><font style="font-family:inherit;font-size:9pt;">year ended</font><font style="font-family:inherit;font-size:9pt;"> </font><font style="font-family:inherit;font-size:9pt;">December 31, 2015</font><font style="font-family:inherit;font-size:9pt;">, the Company recognized an increase to patient service revenues as a result of changes in estimates to third-party settlements related to prior years of approximately </font><font style="font-family:inherit;font-size:9pt;">$2.3 million</font><font style="font-family:inherit;font-size:9pt;"> compared to a reduction to patient service revenues of </font><font style="font-family:inherit;font-size:9pt;">$104,000</font><font style="font-family:inherit;font-size:9pt;"> during the </font><font style="font-family:inherit;font-size:9pt;">year ended</font><font style="font-family:inherit;font-size:9pt;"> </font><font style="font-family:inherit;font-size:9pt;">December 31, 2014</font><font style="font-family:inherit;font-size:9pt;">. These adjustments were related to </font><font style="font-family:inherit;font-size:9pt;">two</font><font style="font-family:inherit;font-size:9pt;"> of the Company's surgical hospitals that were acquired in connection with the acquisition of Symbion on </font><font style="font-family:inherit;font-size:9pt;">November 3, 2014</font><font style="font-family:inherit;font-size:9pt;">.</font></div></div>

Files In Submission

Name	View Source	Status
0001638833-16-000019-index-headers.html	Edgar Link	pending
0001638833-16-000019-index.html	Edgar Link	pending
0001638833-16-000019.txt	Edgar Link	pending
0001638833-16-000019-xbrl.zip	Edgar Link	pending
a201510-kexhibit311.htm	Edgar Link	pending
a201510-kexhibit312.htm	Edgar Link	pending
a201510-kexhibit321.htm	Edgar Link	pending
a201510-kexhibit322.htm	Edgar Link	pending
a201510-kfiling.htm	Edgar Link	pending
exhibit1021highwoodslease.htm	Edgar Link	pending
exhibit211subsidiaries.htm	Edgar Link	pending
exhibit231consent-ey.htm	Edgar Link	pending
exhibit232consent-bdo.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgry-20151231.xml	Edgar Link	completed
sgry-20151231.xsd	Edgar Link	pending
sgry-20151231_cal.xml	Edgar Link	unprocessable
sgry-20151231_def.xml	Edgar Link	unprocessable
sgry-20151231_lab.xml	Edgar Link	unprocessable
sgry-20151231_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending
surgerypartnersstockgraph.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGRY
Surgery Partners, Inc. Stock $sgry

2014 Q4 Form 10-K Financial Statement

#000163883316000019 Filed on March 11, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGRY Surgery Partners, Inc. Stock $sgry

2014 Q4 Form 10-K Financial Statement

#000163883316000019 Filed on March 11, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGRY
Surgery Partners, Inc. Stock $sgry